scorecardresearch
Add as a preferred source on Google
Tuesday, April 21, 2026
TopicJohnson and Johnson

Topic: Johnson and Johnson

Rs 1 crore damages for ‘blatant infringement’: Johnson & Johnson’s big win in court against ORS copycats

New Delhi: The Delhi High Court has awarded damages of Rs 1.2 crore to multinational pharma company Johnson & Johnson in an infringement case...

Johnson & Johnson granted Rs 3.34 crore in damages by HC, what was the counterfeit products case

Offender was found to be a person, who ran a company by the name of Medserve. All seized counterfeit products can be destroyed by the healthcare giant, says HC.

Two doses of J&J’s vaccine slashes Omicron hospital stays in South Africa by up to 85%

The results are a welcome bit of news amid the explosive rise of Omicron cases and evidence that the strain can evade the protection that normally stems from vaccination.

Johnson & Johnson vaccine doesn’t provide antibody protection against Omicron, lab study finds

The J&J vaccine appears to provide some defense against Omicron, perhaps via other means such as stimulation of immune cells, according to a South African virologist.

US scientists suggest link between J&J vaccine and brain blood clots, but warn against panic

Researchers noted that the risk of blood clots should be considered in context of the vaccine’s efficacy, saying it is effective in offering protection from severe Covid-19.

Moderna, J&J boosters get US CDC’s backing, paving way for next shots

The CDC said eligible people may choose a different booster from the vaccine they originally received, granting more flexibility to patients and doctors.

No clarity on India launch of single-dose J&J Covid jab as talks focus on indemnity hurdle

US pharmaceutical companies like Moderna, Pfizer and Johnson & Johnson have asked for indemnity against legal liability but the Government of India has not been inclined to give it.

J&J Covid vaccine gets emergency use nod in India. Here’s how the single-dose jab works

J&J became the fifth vaccine to get an emergency nod in the country, after Covishield, Covaxin, Sputnik V and Moderna.

J&J’s Covid vaccine produces fewer antibodies against Delta variant, study finds

The study, released on bioRxiv, found that J&J’s shot produced roughly five-fold lower levels of antibodies against Delta strain compared to levels raised against an early strain.

US FDA puts new warning on J&J’s Covid vaccine for rare immune disorder

The Food and Drug Administration said it was adding the warning after 100 reports of Guillain-Barré Syndrome among people who had received the shot.

On Camera

Why has US not defeated Iran yet? Because Trump wants to win on the cheap

Trump's goal of ending the Iranian nuclear programme cannot be accomplished without overthrowing the Islamic regime in Iran, which is likely not possible without a ground invasion.

As Strait of Hormuz shuts again, uncertainty grips global trade & energy markets

Oil prices jumped more than 5 percent Monday, on fears that the ceasefire between the ‌US and Iran could also collapse.

Why Siliguri Corridor is strategically important for India & how it is being secured | Cut The Clutter

This special edition of Cut The Clutter, straight from the Siliguri corridor, details the strategic importance of the narrow strip of land in West Bengal, and how it’s a vital link connecting the Northeast to the rest of India.

Trump, Netanyahu’s Iran gamble: The regime change rebound

American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.